Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Modeling Fragile X Syndrome in Drosophila.

Drozd M, Bardoni B, Capovilla M.

Front Mol Neurosci. 2018 Apr 16;11:124. doi: 10.3389/fnmol.2018.00124. eCollection 2018. Review.

2.

Of Men and Mice: Modeling the Fragile X Syndrome.

Dahlhaus R.

Front Mol Neurosci. 2018 Mar 15;11:41. doi: 10.3389/fnmol.2018.00041. eCollection 2018.

3.

Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.

Jawaid S, Kidd GJ, Wang J, Swetlik C, Dutta R, Trapp BD.

Glia. 2018 Apr;66(4):789-800. doi: 10.1002/glia.23284. Epub 2017 Dec 23.

PMID:
29274095
4.

Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.

Zhang N, Peng Z, Tong X, Lindemeyer AK, Cetina Y, Huang CS, Olsen RW, Otis TS, Houser CR.

Exp Neurol. 2017 Nov;297:168-178. doi: 10.1016/j.expneurol.2017.08.008. Epub 2017 Aug 16.

PMID:
28822839
5.

Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.

Filippini A, Bonini D, Lacoux C, Pacini L, Zingariello M, Sancillo L, Bosisio D, Salvi V, Mingardi J, La Via L, Zalfa F, Bagni C, Barbon A.

RNA Biol. 2017 Nov 2;14(11):1580-1591. doi: 10.1080/15476286.2017.1338232. Epub 2017 Sep 5.

6.

Screening the Molecular Framework Underlying Local Dendritic mRNA Translation.

Namjoshi SV, Raab-Graham KF.

Front Mol Neurosci. 2017 Feb 24;10:45. doi: 10.3389/fnmol.2017.00045. eCollection 2017. Review.

7.

Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF.

Brain. 2017 Mar 1;140(3):582-598. doi: 10.1093/brain/aww357.

8.

The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation.

Kim DY, Yu J, Mui RK, Niibori R, Taufique HB, Aslam R, Semple JW, Cordes SP.

Dis Model Mech. 2017 May 1;10(5):581-595. doi: 10.1242/dmm.027433. Epub 2017 Jan 12.

9.

Altered Translational Control of Fragile X Mental Retardation Protein on Myelin Proteins in Neuropsychiatric Disorders.

Jeon SJ, Ryu JH, Bahn GH.

Biomol Ther (Seoul). 2017 May 1;25(3):231-238. doi: 10.4062/biomolther.2016.042. Review.

10.

Defective phosphoinositide metabolism in autism.

Gross C.

J Neurosci Res. 2017 May;95(5):1161-1173. doi: 10.1002/jnr.23797. Epub 2016 Jul 4. Review.

11.

Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.

Kashima R, Roy S, Ascano M, Martinez-Cerdeno V, Ariza-Torres J, Kim S, Louie J, Lu Y, Leyton P, Bloch KD, Kornberg TB, Hagerman PJ, Hagerman R, Lagna G, Hata A.

Sci Signal. 2016 Jun 7;9(431):ra58. doi: 10.1126/scisignal.aaf6060.

12.

Astrocyte-Secreted Factors Selectively Alter Neural Stem and Progenitor Cell Proliferation in the Fragile X Mouse.

Sourial M, Doering LC.

Front Cell Neurosci. 2016 May 18;10:126. doi: 10.3389/fncel.2016.00126. eCollection 2016.

13.

Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.

Tabet R, Moutin E, Becker JA, Heintz D, Fouillen L, Flatter E, Krężel W, Alunni V, Koebel P, Dembélé D, Tassone F, Bardoni B, Mandel JL, Vitale N, Muller D, Le Merrer J, Moine H.

Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3619-28. doi: 10.1073/pnas.1522631113. Epub 2016 May 27.

14.

Progress toward therapeutic potential for AFQ056 in Fragile X syndrome.

Sourial M, Cheng C, Doering LC.

J Exp Pharmacol. 2013 Jul 16;5:45-54. doi: 10.2147/JEP.S27044. eCollection 2013. Review.

15.

Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Fung LK, Reiss AL.

Biol Psychiatry. 2016 Jul 15;80(2):100-111. doi: 10.1016/j.biopsych.2015.12.015. Epub 2015 Dec 18. Review.

16.

Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP.

Suhl JA, Warren ST.

J Exp Neurosci. 2015 Dec 8;9(Suppl 2):35-41. doi: 10.4137/JEN.S25524. eCollection 2015. Review.

17.

Zfrp8 forms a complex with fragile-X mental retardation protein and regulates its localization and function.

Tan W, Schauder C, Naryshkina T, Minakhina S, Steward R.

Dev Biol. 2016 Feb 15;410(2):202-212. doi: 10.1016/j.ydbio.2015.12.008. Epub 2016 Jan 7.

18.

Novel RNA- and FMRP-binding protein TRF2-S regulates axonal mRNA transport and presynaptic plasticity.

Zhang P, Abdelmohsen K, Liu Y, Tominaga-Yamanaka K, Yoon JH, Ioannis G, Martindale JL, Zhang Y, Becker KG, Yang IH, Gorospe M, Mattson MP.

Nat Commun. 2015 Nov 20;6:8888. doi: 10.1038/ncomms9888.

19.

Reduction of α1GABAA receptor mediated by tyrosine kinase C (PKC) phosphorylation in a mouse model of fragile X syndrome.

Zhao W, Wang J, Song S, Li F, Yuan F.

Int J Clin Exp Med. 2015 Aug 15;8(8):13219-26. eCollection 2015.

20.

Dysregulation and restoration of translational homeostasis in fragile X syndrome.

Richter JD, Bassell GJ, Klann E.

Nat Rev Neurosci. 2015 Oct;16(10):595-605. doi: 10.1038/nrn4001. Epub 2015 Sep 9. Review.

Supplemental Content

Support Center